loading
전일 마감가:
$1.24
열려 있는:
$1.24
하루 거래량:
1.01M
Relative Volume:
0.95
시가총액:
$83.97M
수익:
-
순이익/손실:
$-192.96M
주가수익비율:
-0.3879
EPS:
-3.3
순현금흐름:
$-167.04M
1주 성능:
+8.47%
1개월 성능:
+5.79%
6개월 성능:
-46.44%
1년 성능:
-66.62%
1일 변동 폭
Value
$1.225
$1.32
1주일 범위
Value
$1.14
$1.32
52주 변동 폭
Value
$0.783
$5.66

Ventyx Biosciences Inc Stock (VTYX) Company Profile

Name
명칭
Ventyx Biosciences Inc
Name
전화
(858) 945-2393
Name
주소
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Name
직원
79
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
VTYX's Discussions on Twitter

VTYX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VTYX
Ventyx Biosciences Inc
1.28 83.97M 0 -192.96M -167.04M -3.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
503.50 126.09B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
568.91 64.01B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
629.51 36.63B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
257.19 30.64B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.77 27.24B 3.81B -644.79M -669.77M -6.24

Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-03-12 업그레이드 Oppenheimer Perform → Outperform
2024-03-12 업그레이드 Wells Fargo Equal Weight → Overweight
2023-11-07 다운그레이드 H.C. Wainwright Buy → Neutral
2023-11-07 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-11-07 다운그레이드 Oppenheimer Outperform → Perform
2023-11-07 다운그레이드 Stifel Buy → Hold
2023-11-07 다운그레이드 Wells Fargo Overweight → Equal Weight
2023-06-14 재개 Credit Suisse Outperform
2023-03-21 개시 Wells Fargo Overweight
2022-12-19 개시 Goldman Buy
2022-11-17 개시 Morgan Stanley Overweight
2022-09-07 개시 Stifel Buy
2022-09-01 개시 H.C. Wainwright Buy
2022-05-09 개시 Credit Suisse Outperform
2022-03-31 개시 Canaccord Genuity Buy
2022-02-01 개시 Oppenheimer Outperform
2021-11-15 개시 Jefferies Buy
2021-11-15 개시 Piper Sandler Overweight
모두보기

Ventyx Biosciences Inc 주식(VTYX)의 최신 뉴스

pulisher
Apr 29, 2025

Geode Capital Management LLC Increases Stock Position in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Apr 29, 2025
pulisher
Apr 29, 2025

Renaissance Technologies LLC Acquires 310,800 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Stock Market Recap: Ventyx Biosciences Inc (VTYX) Concludes at 1.15, a -4.96 Surge/Decline - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Ventyx Biosciences Inc’s Market Journey: Closing Strong at 1.43, Up 0.70 - DWinneX

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

The Psychology of Ventyx Biosciences Inc Inc. (VTYX) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

JPMorgan Chase & Co. Trims Stake in Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

VTYX FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class ActionVTYX - The Globe and Mail

Apr 24, 2025
pulisher
Apr 24, 2025

Trading Day Review: Ventyx Biosciences Inc (VTYX) Loses Momentum, Closing at 1.16 - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Ventyx Biosciences Inc [NASDAQ: VTYX] Sees Decrease in Stock Value - knoxdaily.com

Apr 24, 2025
pulisher
Apr 23, 2025

Ventyx Biosciences Inc (VTYX) stock analysis: A comprehensive overview - uspostnews.com

Apr 23, 2025
pulisher
Apr 14, 2025

Arthralgia Market to Reach New Heights in Growth by 2032, DelveInsight Predicts | Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis - The Globe and Mail

Apr 14, 2025
pulisher
Apr 11, 2025

VENTYX INVESTOR UPDATE: Ventyx’s (Nasdaq:VTYX) Board is Being Investigated for Insider Trading, Long-term Investors Are Urged to Contact the Firm for Details - ACCESS Newswire

Apr 11, 2025
pulisher
Apr 09, 2025

Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact Levi & Korsinsky about pending Class ActionVTYX - ACCESS Newswire

Apr 09, 2025
pulisher
Apr 08, 2025

Is the Ventyx Biosciences Inc (NASDAQ:VTYX) stock an investment opportunity? - uspostnews.com

Apr 08, 2025
pulisher
Apr 07, 2025

Ventyx Biosciences stock hits 52-week low at $0.89 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

Ventyx Biosciences stock hits 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Is Ventyx Biosciences Inc (NASDAQ: VTYX) Still Trending? - stocksregister.com

Apr 07, 2025
pulisher
Apr 04, 2025

Ventyx Biosciences chief scientific officer John Nuss sells $2,019 in shares - Investing.com India

Apr 04, 2025
pulisher
Apr 02, 2025

VTYX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ventyx Biosciences, Inc. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

Shareholders that lost money on Ventyx Biosciences, Inc.(VTYX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

Stock Traders Purchase Large Volume of Call Options on Ventyx Biosciences (NASDAQ:VTYX) - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Ventyx boosts advisory board with top scientists By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Ventyx boosts advisory board with top scientists - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

7 World-Class NLRP3 Experts Join Ventyx as Phase 2 Trials Advance in Parkinson's Disease - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Insiders' US$1.26m Investments In Red Following Ventyx Biosciences' US$11m Dip In Market Value - simplywall.st

Mar 31, 2025
pulisher
Mar 28, 2025

Ventyx Biosciences stock hits 52-week low at $1.21 amid market challenges - Investing.com

Mar 28, 2025
pulisher
Mar 27, 2025

VTYX Stock Sees Decline of Approximately -9.63% in Last Five Days - knoxdaily.com

Mar 27, 2025
pulisher
Mar 21, 2025

Ventyx Biosciences stock hits 52-week low at $1.28 amid market challenges - Investing.com Australia

Mar 21, 2025
pulisher
Mar 15, 2025

Ventyx Biosciences Faces Supply Chain Risks Amidst U.S.-China Tensions and Regulatory Challenges - MSN

Mar 15, 2025
pulisher
Mar 11, 2025

Ventyx Biosciences stock hits 52-week low at $1.37 amid market challenges - Investing.com Australia

Mar 11, 2025
pulisher
Mar 10, 2025

Rhumbline Advisers Acquires 40,813 Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX) - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Ventyx Biosciences, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your Rights – VTYX - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 04, 2025

Ventyx Biosciences Reports 2024 Financial Results and Progress - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Levi & Korsinsky Notifies Shareholders of Ventyx Biosciences, Inc.(VTYX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 03, 2025

Ventyx Biosciences stock hits 52-week low at $1.41 amid market challenges - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

Ventyx Biosciences stock hits 52-week low at $1.41 amid market challenges By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Class Action Filed Against Ventyx Biosciences, Inc. (VTYX)April 30, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Mar 03, 2025

Ventyx Biosciences Inc (VTYX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.79
price up icon 0.78%
$71.40
price up icon 2.20%
$32.71
price up icon 0.52%
$23.62
price down icon 2.03%
$104.00
price up icon 0.00%
biotechnology ONC
$249.77
price up icon 0.12%
자본화:     |  볼륨(24시간):